Synthesis and characterisation of NS13558: a new important tool for addressing KCa1.1 channel function ex vivo

Bo Hjorth Bentzen1, Rune Wederkinck Andersen, Søren-Peter Olesen

  • 1Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Blegdamsvej 3, 2200, Copenhagen, Denmark.

Insights

Pharmacological activation of the large-conductance Ca(2+)-activated K(+) channel (KCa1.1) protects the heart from injury. A new inactive analogue confirms KCa1.1 channels are key to this cardioprotection.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Mitochondrial Physiology

Background:

  • The large-conductance Ca(2+)-activated K(+) channel (KCa1.1) in cardiac mitochondria is a target for cardioprotection against ischemia-reperfusion injury.
  • Concerns exist regarding the selectivity of pharmacological activators like NS11021.
  • Developing selective tools is crucial for understanding KCa1.1 channel function.

Purpose of the Study:

  • To synthesize and validate a structurally related, biologically inactive analogue of NS11021 (NS13558) to assess the selectivity of KCa1.1 channel activation.
  • To confirm the role of KCa1.1 channels in mediating cardioprotection afforded by NS11021.
  • To establish a novel methodological approach for investigating KCa1.1 channel function.

Main Methods:

  • Synthesis of NS13558, a methylated analogue of NS11021.
  • In vitro electrophysiology to assess KCa1.1 channel activity and off-target effects.
  • In vivo studies using isolated perfused rat hearts subjected to ischemia-reperfusion injury.

Main Results:

  • NS13558 showed no significant activation of cloned human KCa1.1 channels but retained comparable activity on other cardiac ion channels as NS11021.
  • NS11021 significantly reduced infarct size in a rat model of ischemia-reperfusion (from 29% to 7%).
  • NS13558 did not provide any cardioprotection, with infarct size remaining similar to controls.

Conclusions:

  • NS11021 exerts its cardioprotective effects primarily through the activation of KCa1.1 channels.
  • KCa1.1 channels play a critical role in mitigating ischemia-reperfusion injury.
  • The combination of NS11021 and its inactive analogue NS13558 provides a valuable tool for studying KCa1.1 channel function in physiological and pathophysiological contexts.